Medicare Enrolled
Dr. Jeffery Alford, MD
Family Medicine · Sugarland, TX
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alford?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alford
Dr. Jeffery Alford is a family medicine specialist in Sugarland, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Alford performed 4,014 Medicare services across 1,366 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alford received a total of $10,997 from 69 pharmaceutical and/or device companies across 628 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alford is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in TX
$10,997 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,014
Medicare services
Top 5% in TX for family medicine
1,366
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~201 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,229 | $37 | $85 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
911 | $36 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
588 | $87 | $135 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
499 | $29 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
287 | $56 | $95 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
70 | $9 | $70 |
| Annual depression screening | 67 | $18 | $35 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
60 | $62 | $165 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
60 | $93 | $302 |
| Central arterial pressure analysis with physician review This procedure involves analyzing pressure within the central arteries and includes a review of the results by a physician. |
57 | $12 | $20 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
45 | $86 | $525 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
26 | $138 | $500 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
23 | $14 | $60 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $80 | $150 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
18 | $15 | $35 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $127 | $180 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $137 | $180 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
13 | $2 | $35 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
11 | $36 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
3.6% medium
95.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,997
Total received (2018-2024)
Avg $1,571/year across 7 years
Top 4% in TX for family medicine
69
Companies
628
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,984 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,743
2023
$1,521
2022
$1,606
2021
$1,550
2020
$792
2019
$1,861
2018
$1,924
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,070
Novo Nordisk Inc
$942
AstraZeneca Pharmaceuticals LP
$922
Lilly USA, LLC
$871
Boehringer Ingelheim Pharmaceuticals, Inc.
$794
GlaxoSmithKline, LLC.
$626
Amarin Pharma Inc.
$461
PFIZER INC.
$457
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$359
ABBVIE INC.
$314
AbbVie Inc.
$306
Kowa Pharmaceuticals America, Inc.
$302
Takeda Pharmaceuticals U.S.A., Inc.
$255
Merck Sharp & Dohme Corporation
$245
SANOFI-AVENTIS U.S. LLC
$236
Bayer HealthCare Pharmaceuticals Inc.
$184
Janssen Pharmaceuticals, Inc
$180
Antares Pharma, Inc.
$172
Merck Sharp & Dohme LLC
$162
Allergan, Inc.
$152
Bayer Healthcare Pharmaceuticals Inc.
$150
Nobel Biocare USA
$147
Medtronic Vascular, Inc.
$126
Novartis Pharmaceuticals Corporation
$124
Ironshore Pharmaceuticals Inc.
$123
Eisai Inc.
$103
SANOFI PASTEUR INC.
$78
Genentech USA, Inc.
$68
IDORSIA PHARMACEUTICALS US INC
$64
Esperion Therapeutics, Inc.
$63
RedHill Biopharma Inc.
$60
Actelion Pharmaceuticals US, Inc.
$58
Bausch Health US, LLC
$55
Astellas Pharma US Inc
$52
Biohaven Pharmaceutical Holding Company Ltd.
$51
Renalytix AI, Inc.
$42
Sumitomo Pharma America, Inc.
$36
Abbott Laboratories
$36
Radius Health, Inc.
$35
Exact Sciences Corporation
$33
Biohaven Pharmaceuticals, Inc.
$30
Endo Pharmaceuticals Inc.
$28
Corium, LLC
$27
Amneal Pharmaceuticals LLC
$25
Hologic, LLC
$24
Supernus Pharmaceuticals, Inc.
$23
Mannkind Corporation
$22
Tolmar, Inc.
$21
Optinose US, Inc.
$19
Shield Therapeutics Inc
$17
PROCEPT BioRobotics Corporation
$16
Althera Pharmaceuticals LLC
$16
Azurity Pharmaceuticals, Inc.
$15
Scilex Pharmaceuticals Inc.
$14
Nuvectra Corporation
$14
SHIELD THERAPEUTICS INC
$14
EISAI INC.
$14
TOLMAR Pharmaceuticals, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$13
TherapeuticsMD, Inc.
$13
Neos Therapeutics, LP
$13
Bard Peripheral Vascular, Inc.
$13
AMAG Pharmaceuticals, Inc.
$13
Synergy Pharmaceuticals Inc
$13
DEXCOM, INC.
$13
IBSA Pharma Inc.
$12
Adlon Therapeutics L.P.
$11
Aytu BioScience, Inc
$11
Dynavax Technologies Corporation
$3
Top 3 companies account for 26.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADACEL · ADHANSIA XR · AFREZZA · AIRSUPRA · AJOVY · ANNOVERA · ANORO ELLIPTA · APLENZIN · AQUABEAM SYSTEM · AREXVY · AZSTARYS · Adthyza · Adzenys XR-ODT · Aemcolo · Aimovig · Algovita · Aptima HPV · BASAGLAR · BREZTRI · BYDUREON · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CYCLOSET · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · ELIGARD · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Endurant · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · FreeStyle Libre · GARDASIL · GARDASIL 9 · GATTEX · GEMTESA · Heplisav-B · INTRAROSA · JANUVIA · JARDIANCE · JATENZO · Jornay PM 20mg capsules (Bottle of 100) · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · LEQVIO · LINZESS · LYRICA · Levemir · Livalo · MOUNJARO · NASCOBAL · NEXLETOL · NOBELACTIVE · NOCDURNA · NUCALA · NURTEC ODT · Natesto · OTREXUP · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QELBREE · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Talicia · Tirosint · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · UNITHROID · VRAYLAR · VYVANSE · Vascepa · Venovo · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xhance · Xofluza · Xultophy 100/3.6 · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in TX.
Equivalent to $274 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
1,306
Per 100K population
151.9
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Alford is a remote monitoring specialist, with above-average Medicare volume (top 5% in TX), with low-engagement industry engagement in the top 4% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Alford experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. Alford performed 1,229 remote patient monitoring device, 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alford receive payments from pharmaceutical companies?
Yes. Dr. Alford received a total of $10,997 from 69 companies across 628 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alford's costs compare to other family medicine physicians in Sugarland?
Dr. Alford's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Sugarland
Browse family medicine physicians in Sugarland ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology